What is BDI Biotech?
Headquartered in Spain, BDI Biotech operates as a specialized biotechnology service provider that bridges the gap between innovative research and industrial-scale manufacturing. The company offers a comprehensive suite of solutions, including contract production and process optimization, which allows clients to bypass the need for extensive in-house infrastructure. By leveraging proprietary biotransformation techniques, BDI Biotech enables its partners to enhance product quality while maintaining cost-efficiency. Their market position is defined by a deep technical proficiency in fungal expression systems and a commitment to high-standard R&D, making them an essential partner for firms operating in the rapidly evolving biopharmaceutical and nutraceutical industries.
How much funding has BDI Biotech raised?
BDI Biotech has raised a total of $2.3M across 1 funding round:
Private Equity
$2.3M
Private Equity (2018): $2.3M with participation from Inveready Technology Investment and Dyadic International Inc.
Key Investors in BDI Biotech
Inveready Technology Investment
Inveready is a prominent Spanish financial services firm specializing in investment solutions and wealth management, focusing on small and mid-market segments.
Dyadic International Inc.
Dyadic International is a global biotechnology company that develops a biopharmaceutical gene expression platform based on the fungus Thermothelomyces heterothallica.
What's next for BDI Biotech?
With the recent influx of capital, BDI Biotech is poised to deepen its strategic focus on scaling its biomanufacturing capabilities. The company is expected to prioritize the expansion of its contract production facilities, allowing for increased throughput in the development of live biotherapeutics and complex proteins. Furthermore, the firm will likely leverage this financial backing to enhance its proprietary technology stack, ensuring it remains at the forefront of bioprocess innovation. By strengthening its R&D infrastructure, BDI Biotech aims to solidify its role as a critical enabler for global life science companies seeking to optimize their production pipelines and accelerate time-to-market for next-generation therapeutic products.
See full BDI Biotech company page
